Microsoft's commercial contracted backlog more than doubled year-over-year to $625 billion, fueled by AI demand. However, a closer look reveals customer concentration risks, slower near-term revenue conversion, and soaring capital expenditures that temper the bullish narrative.
Fueled by record-breaking demand for its HOKA and UGG brands, Deckers Outdoor posts a robust Q3, beating expectations. The company credits disciplined full-price selling and strategic marketplace management for driving growth across all regions, leading to an upward revision of its fiscal 2026 guidance.
Ondas Holdings' flagship Optimus drone system has received the Defense Contract Management Agency's critical 'Blue List' certification, clearing it for broader U.S. defense and national security deployment. The milestone has ignited a surge in the company's stock while prompting analysts to scrutinize its long-term path to converting regulatory approval into sustainable revenue.
Bread Financial (NYSE: BFH) delivered robust fourth-quarter and full-year 2025 results, meeting expectations through strategic partner expansions, improved credit health, and strengthened capital positioning. Management outlines a 2026 roadmap focused on sustainable growth, deposit mix optimization, and leveraging AI across operations.
Cullen/Frost Bankers Inc. reports strong quarterly earnings, driven by disciplined credit management and strategic expansion, while outlining a cautious yet opportunistic outlook for 2026 in a shifting rate environment.
Arthur J. Gallagher & Co. reported robust fourth-quarter results, driven by a potent mix of organic expansion and strategic acquisitions like AssuredPartners. Management projects sustained mid-single-digit growth for 2026, backed by a significant capital reserve for further mergers and acquisitions.
Howard Wealth Management's significant purchase of the Invesco BulletShares 2030 Corporate Bond ETF (BSCU) highlights a strategic move towards defined-maturity fixed income, underscoring a disciplined approach to building cash flow ladders in a volatile rate environment.
While buying the dip can be a profitable strategy, investors should steer clear of C3.ai and The Trade Desk. Significant operational challenges and management turmoil suggest their recent plunges may not be over.
Lumen Technologies pivots decisively toward the enterprise sector, achieving a pioneering AI management certification while divesting its remaining consumer fiber assets to AT&T, signaling a strategic consolidation around business and government services.
Eldorado Gold is set to acquire Foran Mining in an all-stock transaction valued at C$3.8 billion, aiming to create a diversified gold and copper producer with two flagship projects slated to begin production in 2026, significantly boosting its output and cash flow profile.
A notable easing of US-Iran tensions has buoyed investor confidence across Gulf bourses, creating a favorable backdrop for stable, income-generating equities. We analyze three regional dividend stocks offering potential portfolio resilience amid shifting market dynamics.
Industrial battery giant EnerSys (ENS) is set to report its fiscal fourth-quarter results after Wednesday's market close. Investors are weighing strong recent performance against a history of revenue misses and a tempered growth outlook.
Eli Lilly's $3.5 billion investment in a new Pennsylvania facility for injectable weight-loss drugs, including retatrutide, spotlights its aggressive expansion in the obesity market. This strategic move, coupled with strong analyst sentiment and upcoming earnings, intensifies focus on the company's growth trajectory and premium valuation.
Amgen has terminated its collaboration with Kyowa Kirin on the atopic dermatitis drug rocatinlimab, handing full development rights back to the Japanese partner. The strategic shift comes as Amgen's stock trades above most fair value estimates, raising questions about its current valuation amid pipeline recalibration.
Palantir Technologies' stock surged after hours as the data analytics firm reported record quarterly results, fueled by its AI platform. CEO Alex Karp hailed an 'iconic' performance while warning that the company's dominance creates societal and political tensions.
As Regal Rexnord prepares to release its fourth-quarter results, investors are watching to see if the industrial automation leader can sustain its recent stock momentum and deliver on growth forecasts in a mixed earnings season for machinery peers.
Aerospace and defense component maker Woodward, Inc. (WWD) is commanding investor attention following a robust first-quarter earnings beat, a significant dividend hike, and an upgraded full-year outlook. The strong results have propelled the stock to new highs, reigniting the debate over its valuation in a rapidly evolving industry.
Twist Bioscience's proprietary silicon-based DNA manufacturing platform is driving double-digit revenue growth and margin expansion, positioning the synthetic biology tools provider on a clear path to adjusted EBITDA breakeven by fiscal 2026.
New late-breaking data for Nektar Therapeutics' lead drug candidate, rezpegaldesleukin, suggests systemic anti-inflammatory benefits in patients with comorbid asthma, potentially expanding its market reach and strengthening the investment case for the biopharma firm.
Beyond the headlines of rocket launches, companies building the critical infrastructure for the orbital economy are gaining strategic importance. Redwire Corporation (NYSE: RDW), with its niche technologies powering everything from lunar missions to potential space-based data centers, presents a compelling, if complex, investment thesis in the burgeoning space sector.
